Associate Director, SEC Reporting & Technical Accounting

Associate Director, SEC Reporting & Technical Accounting Odyssey Therapeutics is propelling drug development beyond what is now possible to deliver medicines that address critical needs of patients with inflammatory and immunology diseases. We achieve unprecedented speed and efficiency by bringing together a target-centric approach, a toolbox of cutting‑edge technologies, and a team of accomplished, world‑class drug hunters. By reimagining the drug development process, we are creating a deep and broad drug pipeline that holds the potential to transform human health. The opportunity: The Associate Director, SEC Reporting & Technical Accounting, will play a critical role in leading and scaling Odyssey’s public company financial reporting, technical accounting, and SOX compliance functions as a newly public biotech company. Reporting to the Assistant Controller, this individual will drive the preparation of SEC filings, support quarterly and annual reporting processes, research and document complex accounting matters, and strengthen the controls and reporting infrastructure required of a newly public biotechnology company. The ideal candidate is an experienced public company accounting professional who thrives at the intersection of financial reporting, technical accounting, cross‑functional execution, and operational excellence, and who brings deep knowledge of U.S. GAAP, SEC disclosure requirements, and public company best practices. Your primary objectives will be: SEC Reporting Lead the preparation and project management of the company's SEC filings, including Forms 10‑Q, 10‑K, 8‑K, proxy statement support, and other periodic or ad hoc filings. Own the financial statements, footnotes, MD&A support, disclosure checklists, tie‑outs, and review calendar for quarterly and annual reporting deliverables. Coordinate the end‑to‑end SEC reporting timeline with Finance, Legal, external auditors, outside counsel, and other stakeholders to ensure timely and accurate filings. Monitor SEC rules, interpretive guidance, peer company disclosures, and emerging reporting practices; recommend improvements to the company's disclosure approach and processes. Technical Accounting Research, evaluate, and document technical accounting conclusions for complex transactions, including equity and stock‑based compensation, financing arrangements, collaboration and licensing arrangements, leases, clinical accruals, fair value matters, segment reporting, and other areas relevant to a clinical‑stage biotechnology company. Prepare clear, well‑supported technical accounting memoranda and communicate conclusions to Finance leadership and external auditors, and advisors. Monitor new accounting pronouncements and FASB, SEC, and PCAOB developments; assess impact to the company and lead implementation of applicable accounting standards and disclosure updates. Develop, maintain, and enhance accounting policies and procedures as the company scales its public company infrastructure. Support Finance and cross‑functional teams with designated areas of the monthly close process and ongoing management reporting needs. SOX Compliance and Internal Controls Support the design, implementation, and ongoing enhancement of the company’s SOX compliance program as a newly public company, including scoping, risk assessment, control design, and testing. Partner with Finance, IT, Legal, HR, and business process owners to document, evaluate, and improve internal controls over financial reporting, including process narratives, flowcharts, risk and control matrices, and key control evidence. Coordinate with external auditors and SOX advisors on control testing, walkthroughs, audit requests. Help establish and maintain policies, procedures, governance practices, and control‑owner training that support accurate financial reporting, public company readiness, and compliance with SEC and Sarbanes‑Oxley requirements. Maintain a strong control mindset and promote disciplined documentation, review standards, and accountability across reporting workstreams. Leadership & Cross‑Functional Collaboration Serve as a trusted technical accounting and SEC reporting partner to Finance, Legal, Investor Relations, employees, and executive stakeholders. Translate complex accounting and reporting matters into practical guidance for finance and non‑finance audiences. Contribute to the continued build‑out of the company's public company finance infrastructure, including systems, processes, policies, and reporting governance. About you: Bachelor’s degree in accounting or finance required; CPA required. Minimum 7 years of progressive accounting and reporting experience, including SEC reporting, U.S. GAAP technical accounting, and public company disclosure requirements. Big 4 or national public accounting firm experience strongly preferred. Direct experience preparing or reviewing Forms 10‑Q, 10‑K, 8‑K, proxy‑related materials, and SEC‑compliant financial statements and disclosures. Strong knowledge of SEC reporting requirements, Regulation S‑X, Regulation S‑K, disclosure controls, SOX compliance, internal controls over financial reporting, and public company reporting best practices. Demonstrated ability to research complex accounting matters, prepare clear technical accounting memoranda, coordinate audits, and align internal and external stakeholders. Strong project management, communication, analytical judgment, and attention to detail, with the ability to manage multiple priorities in a fast‑paced, rapidly scaling environment. Experience with Active Disclosure and NetSuite, or similar systems preferred. Preferred experience includes biotechnology or life sciences, newly public company environments and accounting matters common to clinical­-stage biotechnology companies. #J-18808-Ljbffr Odyssey Therapeutics, Inc.